CORC

在结果中检索

CORC

浏览/检索结果: 共13条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Large-scale prediction of ADAR-mediated effective human A-to-I RNA editing 期刊论文
BRIEFINGS IN BIOINFORMATICS, 2019, 卷号: 20, 期号: 1
作者:  Shen, Xizhong;  Song, Guangqi;  Wang, Jinlin;  Zhao, Yicheng;  Zhu, Jimin
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/05
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results 期刊论文
HEPATOLOGY INTERNATIONAL, 2019, 卷号: 13, 期号: 3
作者:  Liang, Xieer;  Gao, Zhiliang;  Xie, Qing;  Zhang, Jiming;  Sheng, Jifang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
Is Repeat Abortion a Public Health Problem among Chinese Adolescents? A Cross-Sectional Survey in 30 Provinces 期刊论文
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 卷号: 16, 期号: 5
作者:  Liu, Jinlin;  Wu, Shangchun;  Xu, Jialin;  Temmerman, Marleen;  Zhang, Wei-Hong
收藏  |  浏览/下载：71/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study 期刊论文
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 卷号: 6, 期号: 1
作者:  Hu, Peng;  Shang, Jia;  Zhang, Wenhong;  Gong, Guozhong;  Li, Yongguo
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Increased and sustained HBsAg loss in HBeAg positive CHB patients switched from NUC to Peg-IFN alfa-2a: A randomised open label trial (NEW SWITCH study) 会议论文
作者:  Hu, Peng;  Dou, Xiaoguang;  Jiang, Jian-ning;  Jia, Shang;  Zhang, Wen Hong
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/06
Composition and Interactions of Hepatitis B Virus Quasispecies Defined the Virological Response During Telbivudine Therapy 期刊论文
SCIENTIFIC REPORTS, 2015, 卷号: 5
作者:  Zhou, Bin;  Dong, Hui;  He, Yungang;  Sun, Jian;  Jin, Weirong
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/19
Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 卷号: 30, 期号: 4
作者:  Liang, Xieer;  Cheng, Jun;  Sun, Yongtao;  Chen, Xinyue;  Li, Tong
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19
A multi-center randomized study on the efficacy and safety of switching to peginterferon alpha-2a (40KD) for 48 or 96 weeks in HBeAg positive CHB patients with a prior NUC history for 1 to 3 years: an interim analysis of NEW SWITCH study 会议论文
作者:  Hu, Peng;  Jia, Shang;  Zhang, Wen Hong;  Gong, Guozhong;  Li, Yongguo
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace